drugset / Trial / NCT06772532
A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body
RandomizedCrossoverOpen-labelTreatment
Summary
The main objective of this trial is to investigate relative bioavailability of BI 456906 formulation B and BI 456906 formulation C vs. BI 456906 formulation A.
Timeline
- Start
- 2025-02-10
- Primary completion
- 2025-05-29
- Completion
- 2025-06-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Survodutide | Protein / enzyme biologic | — | Subcutaneous |
Indications
No indication recorded.